Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats

Biomolecules(2025)10.3390/biom15081104Source: DataRank Database

Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats is a research paper published in Biomolecules (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.61)OA: goldTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Tahani Almatrafi,Amira M. Badr ORCID,Sumayya A. Alturaif,Raeesa Mohammed,Abdulaziz Siyal

Live enrichment

PubMed:40867548 PMC:PMC12383837 OpenAlex:https://openalex.org/W4412756066

King Saud University, Riyadh, Saudi Arabia

Grant: ORF-2025-573

FWCI

0.61

Citation Percentile

0.7%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2218-273X/15/8/1104/pdf?version=1753861922

publisherhttps://www.mdpi.com/2218-273X/15/8/1104/pdf?version=1753861922

publisherhttps://www.mdpi.com/2218-273X/15/8/1104/pdf

journalhttps://doi.org/10.3390/biom15081104

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40867548

Fields of Study

Diabetes Treatment and ManagementCardiovascular Function and Risk FactorsMetabolism, Diabetes, and CancerAnimalsSitagliptin PhosphateOxidative StressVascular Endothelial Growth Factor Receptor-1Diabetic CardiomyopathiesVascular Endothelial Growth Factor ARatsMaleDiabetes Mellitus, ExperimentalBlood GlucoseHypoglycemic Agents

MeSH Terms

Sitagliptin PhosphateAnimalsBlood GlucoseDiabetes Mellitus, ExperimentalHypoglycemic AgentsMaleOxidative StressVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor ARatsDiabetic Cardiomyopathies

Keywords

SitagliptinOxidative stressDiabetic cardiomyopathyVEGF receptorsInternal medicineCardiologyMedicineCardiomyopathyReduction (mathematics)Diabetes mellitusEndocrinologyHeart failureType 2 diabetesCardiovascular diseasemyocardial fibrosis

Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats

FAIR Checklist

Authors (7)

Funding (1 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)